• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone

tetano

Editor, Senior Moderator
Vaccine. 2015 Jul 21. pii: S0264-410X(15)00981-0. doi: 10.1016/j.vaccine.2015.06.112. [Epub ahead of print]
[h=1]Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.[/h] Medina J[SUP]1[/SUP], Boukhebza H[SUP]2[/SUP], De Saint Jean A[SUP]3[/SUP], Sodoyer R[SUP]4[/SUP], Legastelois I[SUP]5[/SUP], Moste C[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The yield of influenza antigen production may significantly vary between vaccine strains; for example the A/California/07/09 (H1N1)-X179A vaccine virus, prepared during 2009 influenza pandemic, presented a low antigen yield in eggs compared to other seasonal H1N1 reassortants. In this study a bi-chimeric virus expressing HA and NA genes with A/Puerto Rico/8/34 (H1N1) (PR8) and X179A domains was rescued by reverse genetics using a mixture of Vero/CHOK1 cell lines (Medina et al. [7]). The bi-chimeric virus obtained demonstrated to yield much larger amounts of HA than X179A in eggs as measured by single-radial-immunodiffusion (SRID), the reference method to quantify HA protein in influenza vaccine. Such kind of optimized virus using PR8 backbone derived chimeric glycoproteins could be used as improved seed viruses for vaccine production.
Copyright ? 2015 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Chimeric; Influenza; PR8 backbone; Vaccine

PMID: 26206270 [PubMed - as supplied by publisher]
 
Back
Top Bottom